JPRN-UMIN000034140已完成2 期
Efficacy and safety of dual therapy containing vonopranzan and amoxicillin as first line Helicobacter pylori eradication: a randomized, non-inferiority trial - Vonoprazan-based dual therapy for first line H. pylori eradication
Division of Gastroenterology and Hepatology, Department of Medicine,Nihon University School of Medicine0 个研究点目标入组 335 人开始时间: 2018年9月14日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 335
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Allergy to vonoprazan, amoxicillin, or clarithromycin 2) A history of receiving H. pylori eradication therapy 3) A history of gastric surgery 4) Using PPI 5) Using antibiotics 6) Using steroid 7) Pregnancy 8) Breast-feeding 9) Lack of informed consent 10) Others
研究者
相似试验
已完成
不适用
The efficacy and safety of combination therapy of adoptive immunotherapy with chemotherapy for advanced pancreatic cancerJPRN-UMIN000011177Tokai University School of Medicine20
进行中（未招募）
1 期
Safety and efficacy of combination treatment with rituximab and leflunomide in patients with active rheumatoid arthritis - Rituximab and Leflunomide in RAEUCTR2005-004582-41-GBniversity of Leeds15
进行中（未招募）
不适用
COMET TrialJPRN-jRCTs031180210Yokote Koutaro60
已完成
不适用
Effectiveness and safety of Combination therapy of Ranibizumab and LuseOgliflozin in type 2 diabetes with diabetic Macular Edema, a parallel group comparison with the standard Treatment controlled by Glimepiride, multicenter, randomized, open-label trial. (COMET Trial)JPRN-UMIN000033961Chiba University60
尚未招募
不适用
Helicobacter pylori eradication in childrenDigestive SystemHelicobacter pylori gastritisPaediatricsPACTR201807134057681Pediatric department Faculty of medicine Alexandria university156